SUCCESSFUL THYROIDECTOMY IN SEVERE GRAVES’ DISEASE
A MODIFIED BLOCK-AND-REPLACE APPROACH
DOI:
https://doi.org/10.15605/jafes.040.S1.026Keywords:
Graves’ disease, thyroidectomyAbstract
INTRODUCTION/BACKGROUND
Graves’ disease is the most common cause of autoimmune hyperthyroidism. In severe cases, thyroidectomy is required. The block-and-replace regimen helps achieve euthyroidism preoperatively, but perioperative thyroid instability remains a challenge, particularly in urgent surgical settings.
CASE
A 20-year-old Malay female with severe plaque psoriasis developed a painful goiter and severe thyrotoxicosis following Guselkumab treatment, necessitating carbimazole 30 mg daily. She was initially scheduled for radioactive iodine (RAI) therapy; however, two weeks after her fourth Guselkumab dose, just before her planned RAI, she had thyroid storm. Emergency management included Lugol’s iodine, high-dose propylthiouracil, corticosteroids, and cholestyramine. Due to recent iodine exposure, RAI was no longer a viable option, necessitating an alternative definitive treatment approach.
Methimazole was increased from 20 mg to 25 mg twice daily, successfully lowering free T4 from 27 to 17 pmol/L. However, on the day before her scheduled thyroidectomy, severe hypothyroidism (TSH <0.01 mIU/L, T4 <5 pmol/L) was noted. To rapidly restore euthyroidism, she received a total of 300 mcg of levothyroxine overnight while continuing methimazole. This intervention raised her T4 to 8.3 pmol/L, ensuring safe surgical conditions while mitigating the risk of recurrent thyroid storm in this difficult-to-control case.
CONCLUSION
This case highlights the challenges of perioperative thyroid management in Graves’ disease. High-dose levothyroxine while maintaining methimazole facilitated urgent surgical clearance, balancing the risks of hypothyroidism and thyroid storm. This modified block-and-replace approach may be considered in select cases requiring time-sensitive surgical intervention.
Downloads
References
*
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Nursafinas Rofii, Ooi Chuan Ng

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.




